Dana-Farber Cancer Institute

This is your central portal for breaking news, the latest research and important updates from Dana-Farber Cancer Institute. Bookmark this page and check back often for updates.

Meeting News

Cabozantinib extends PFS as first-line therapy for metastatic renal cell carcinoma

September 11, 2017
MADRID — Cabozantinib significantly extended PFS compared with sunitinib as initial targeted therapy for patients with metastatic renal cell…
FDA NewsPerspective

FDA approves Kymriah as first chimeric antigen receptor T-cell therapy

August 30, 2017
The FDA approved tisagenlecleucel T-suspension for the treatment of children and young adults with B-cell acute lymphoblastic leukemia…
In the Journals Plus

Metastasis-free survival viable endpoint for prostate cancer trials

August 29, 2017
Metastasis-free survival could be a surrogate endpoint for OS in clinical trials designed to evaluate adjuvant therapy options for patients with…

The University of Texas MD Anderson Cancer Center named best cancer hospital in nation

August 8, 2017
The University of Texas MD Anderson Cancer Center has retained its distinction as the No. 1 cancer hospital in the country. MD Anderson tops U.S
In the Journals Plus

Platinum-based chemotherapy shows efficacy in BRCA2-mutated prostate cancer

August 2, 2017
A small group of men with metastatic, castration-resistant prostate

No Stomach For Cancer awards grants to support stomach cancer research

July 18, 2017
No Stomach For Cancer awarded $100,000 worth of grants to fund research related to immunotherapy and use of blood biomarkers to predict early…
Cover Story

Deeper understanding of disease biology may expand sarcoma treatment options

HemOnc Today, July 10, 2017
Sarcomas are the most common tumors in young adults, and they account for 15% of all pediatric cancers. Approximately 12,390 cases are expected to be…
Meeting News

Enzyme activator could be ‘disease-modifying’ treatment for pyruvate kinase deficiency

June 28, 2017
Enzyme activator AG-348 sustained hemoglobin increases in adults with pyruvate kinase deficiency, according to updated data from a phase 2 trial…

St. Jude Children’s Research Hospital named nation’s best for pediatric cancer

June 27, 2017
St. Jude Children’s Research Hospital has been named the best hospital in the nation for children with cancer. The institution tops U.S. News
In the Journals Plus

Midostaurin extends survival in acute myeloid leukemia with FLT3 mutation

June 23, 2017
The addition of midostaurin to standard chemotherapy improved OS and EFS among patients with acute myeloid leukemia and FLT3 mutation, according to…

Warren Alpert Foundation recognizes leaders in cancer immunology

June 13, 2017
Five scientists will receive the Warren Alpert Foundation Prize in recognition of their discoveries in the field of cancer immunology. The…
FDA News

FDA grants orphan drug designation to tucatinib for brain metastases

June 13, 2017
The FDA granted orphan drug designation to tucatinib for the treatment of patients with breast cancer whose disease metastasized to the brain…
Meeting News

Mastectomy more common among US women with triple-negative breast cancer

June 4, 2017
CHICAGO — Women in the United States who underwent neoadjuvant therapy for triple-negative breast cancer appeared more likely than those in…

Dana-Farber Cancer Institute appoints gastrointestinal cancer center director

May 27, 2017
Brian Wolpin , MD, MPH, has been appointed director of the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute. Wolpin is…
In the Journals Plus

Lack of transfusion capabilities linked to underuse of hospice for blood cancers

May 22, 2017
Hematologic oncologists appeared to value hospice but may be concerned about the adequacy of services like transfusion for patients with blood…
Meeting NewsPerspective

Nut consumption reduces risk for colon cancer recurrence

May 18, 2017
Regular consumption of tree nuts conferred considerable benefit to patients with stage III colon cancer, according to observational study results…
In the Journals Plus

Selumetinib fails to improve PFS in KRAS–mutant advanced NSCLC

May 9, 2017
The addition of selumetinib to docetaxel did not improve PFS among patients with KRAS–mutant non–small cell lung cancer, according to…

Leukemia & Lymphoma Society panel explores ‘tsunami’ of financial burdens, potential of immunotherapy

May 3, 2017
Patients continue to face a “tsunami” of financial burdens associated with cancer care, but advances in immunotherapy and precision…
In the Journals Plus

Smokers with pancreatic cancer at risk for shorter survival

May 2, 2017
Patients with pancreatic cancer who smoked near the time of diagnosis were 40% more likely to die after diagnosis than those who never smoked or…
FDA approvals

FDA approves Zejula for maintenance treatment of gynecologic cancers

March 27, 2017
The FDA today approved niraparib for the maintenance treatment of adults with recurrent epithelial ovarian, fallopian tube or primary peritoneal…